A Cross-Sectional Study of Various Imaging and Biochemical Biomarkers in Patients with Diabetic Macular Edema in Different Stages of Diabetic Retinopathy
- PMID: 36176978
- PMCID: PMC9514258
- DOI: 10.2147/OPTH.S377956
A Cross-Sectional Study of Various Imaging and Biochemical Biomarkers in Patients with Diabetic Macular Edema in Different Stages of Diabetic Retinopathy
Abstract
Purpose: To compare which imaging and biochemical biomarkers are associated with different stages of diabetic retinopathy (DR) in type 2 diabetes mellitus patients with diabetic macular edema (DME).
Patients and methods: It was a cross-sectional, observational study that included 100 patients of DME with different stages of DR. Patients were divided into two groups: Group A - DME with non-proliferative diabetic retinopathy (NPDR) and Group B - DME with proliferative diabetic retinopathy (PDR). Group A was further subdivided into three subgroups: A (1) - DME with mild NPDR, A (2) - DME with moderate NPDR, and A (3) - DME with severe NPDR. The primary outcome measure was the association of imaging and biochemical biomarkers with different stages of DR in patients with DME.
Results: Out of 100 patients, Group A (1) had 1, Group A (2) 44, Group A (3) 29, and group: B had 29 patients. As Group A (1) had only one patient, we did not include it in the calculation. The overall mean age of the study population was 54.84+9.87 years, with a male preponderance (76%). The HbA1c levels, serum triglyceride level, serum cholesterol level, and microalbuminuria level showed no significant association with different stages of DR (P>0.05). Still, we found high serum urea levels (p=0.027) in Group B patients. The optical coherence tomography (OCT)-based imaging biomarkers - central subfield thickness (CST), cystoid macular edema (CME), subretinal fluid (SRF), and hyperreflective foci (HRF) - showed no significant association with various stages of DR. The presence of diffuse retinal thickness (DRT) (p=0.04) and the epiretinal membrane (ERM) (p=0.04) showed significant association with Group B patients.
Conclusion: The essential biochemical biomarkers such as serum urea levels and DRT and ERM may be considered an important imaging biomarker for the advanced stage of DR.
Keywords: biochemical biomarkers; central subfield thickness; diffuse retinal thickness; imaging biomarkers; serum urea level.
© 2022 Naveen et al.
Conflict of interest statement
The authors report no financial interest or conflicts of interest in this work.
Similar articles
-
Association of Various Optical Coherence Tomographic Patterns of Diabetic Macular Edema With Central Subfield Thickness and Visual Acuity: A Cross-Sectional Observational Study.Cureus. 2024 Sep 19;16(9):e69731. doi: 10.7759/cureus.69731. eCollection 2024 Sep. Cureus. 2024. PMID: 39429306 Free PMC article.
-
[Association of choroidal thickness with diabetic retinopathy at different stages].Zhonghua Yi Xue Za Zhi. 2015 Aug 25;95(32):2584-8. Zhonghua Yi Xue Za Zhi. 2015. PMID: 26711604 Chinese.
-
Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.Invest Ophthalmol Vis Sci. 2013 May 9;54(5):3378-84. doi: 10.1167/iovs.12-11503. Invest Ophthalmol Vis Sci. 2013. PMID: 23611988
-
Do Genomic Factors Play a Role in Diabetic Retinopathy?J Clin Med. 2020 Jan 14;9(1):216. doi: 10.3390/jcm9010216. J Clin Med. 2020. PMID: 31947513 Free PMC article. Review.
-
The Roles of Vitamins in Diabetic Retinopathy: A Narrative Review.J Clin Med. 2022 Nov 1;11(21):6490. doi: 10.3390/jcm11216490. J Clin Med. 2022. PMID: 36362717 Free PMC article. Review.
Cited by
-
Molecular-Genetic Biomarkers of Diabetic Macular Edema.J Clin Med. 2024 Dec 5;13(23):7426. doi: 10.3390/jcm13237426. J Clin Med. 2024. PMID: 39685883 Free PMC article. Review.
References
-
- International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019.
-
- Asensio-Sánchez VM, Gómez-Ramírez V, Morales-Gómez I, et al. Clinically significant diabetic macular edema: systemic risk factors. Arch Soc Esp Oftalmol. 2008;83(3):173–176. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous